Top

Reactions Weekly

Published in:

01-02-2023 | Anakinra | Case report

Multiple drugs

Infusion reaction, lack of efficacy and off-label use: 2 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Kaleda M, et al. COVID-19 in pediatric patients with rheumatic diseases and the history of macrophage activation syndrome: Retrospective single center study. Pediatric Rheumatology 20 (Suppl. 2): no pagination, Sep 2022. Available from: URL: http://doi.org/10.1186/s12969-022-00729-z

Title: Multiple drugs
Infusion reaction, lack of efficacy and off-label use: 2 case reports
Publication date: 01-02-2023
Publisher: Springer International Publishing
Keywords: Anakinra
Tocilizumab
Azithromycin
Glucocorticoid
Juvenile Rheumatoid Arthritis
Rituximab
Aciclovir
COVID-19
Juvenile Rheumatoid Arthritis
Rituximab
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-33343-7

2024 ASCO Annual Meeting

Springer Medicine

Multiple drugs

Infusion reaction, lack of efficacy and off-label use: 2 case reports

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drugs

Colestyramine/ursodeoxycholic-acid/vitamin-K

Antibacterials/prednisone

Multiple drugs

Prednisone/tocilizumab

Infliximab